IQVIA has partnered with SCRI Development Innovations, the contract research organisation branch of the Sarah Cannon Research Institute (SCRI), aimed at transforming oncology clinical trials for biopharma collaborators worldwide.
This partnership is said to improve trial processes, remove operational challenges, expedite data delivery, and enhance the availability of new therapies to individuals.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
It claims to use IQVIA’s worldwide reach, trial management, and data integration capabilities.
SCRI will contribute its community oncology knowledge and Accelero, an operational model that accelerates trial activation and improves recruitment at SCRI sites within the US.
The model also claims to integrate information from electronic health records directly into electronic capture systems for clinical trials data collection within the US.
This integration is expected to provide sponsors with a pathway to operationalise the treatment development for individuals.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataSarah Cannon Research Institute CEO Dee Anna Smith said: “We are enthusiastic about the impact we can make in transforming clinical trial delivery through our collaboration with IQVIA.
“Through our accelerated operations model, Accelero, SCRI can alleviate the operational burden on research sites, enhance enrolment, and expedite data delivery through our cutting-edge technology solutions.”
IQVIA is a clinical research service and healthcare intelligence provider, and says that its solution portfolio is powered by IQVIA Connected Intelligence.
SCRI is an oncology research organisation conducting community-based trials.
IQVIA research and development solutions president Richard Staub said: “This collaboration embodies our commitment to innovation, efficiency, and delivering superior outcomes for patients by bringing together the best of both organisations and eliminating the complexities often associated with multiple vendors.”
Last June, IQVIA introduced a new trial technology platform, One Home for Sites. This platform simplifies clinical trial management by providing a single sign-on and dashboard for various tasks and systems.
